diabetes increases the risk for medical complications including death.
(1) They appropriately stressed the importance of glycemic control during COVID-19 infections because hyperglycemia may adversely affect pulmonary function and immune response. There are many reasons why COVID-19 patients might have worse glycemic control or be at higher risk than their they were in their pre-Covid-19 state.
We propose four risk factors -along with potential remedies -for diabetes patients with COVID-19, compared to COVID patients without diabetes, which can increase the risk of poor outcomes.
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2) Inadequate glucose monitoring. Optimal hospital glycemic control requires frequent blood glucose (BG) tests. (4) For COVID-19 patients a nurse must wear personal protective gear for fingersticking. In some cases, a nurse will not have time or adequate protective equipment resulting in suboptimal testing. Some physicians will order infrequent testing to minimize direct contact between the nurse and patient. In some hospitals, trials are underway to use continuous glucose monitoring (CGM) systems (5) to minimize contact. Currently, no CGM is cleared for use in the hospital so this method cannot be recommended outside of a clincal trial.
3) Lack of contact with healthcare professionals. COVID-19 patients with diabetes will be quarantined and unable to visit their physicians. Journal Pre-proof J o u r n a l P r e -p r o o f 
In mechanically ventilated adults with COVID-19 and respiratory failure (without ARDS), we suggest against the routine use of systemic corticosteroids. Weak recommendation, low-quality evidence.
In mechanically ventilated adults with COVID-19 and ARDS, we suggest using systemic corticosteroids, over not using corticosteroids. Weak recommendation, low-quality evidence. Remark: The majority of our panel support a weak recommendation (i.e. suggestion) to use steroids in the sickest patients with COVID-19 and ARDS. However, because of the very low-quality evidence, some experts on the panel preferred not to issue a recommendation until higher quality direct evidence is available.
